Protagenic Therapeutics Inc. (PTIX)
0.37
-0.05 (-11.48%)
At close: Apr 04, 2025, 3:59 PM
0.32
-12.57%
After-hours: Apr 04, 2025, 05:59 PM EDT
-11.48% (1D)
| Bid | 0.31 |
| Market Cap | 2.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -0.29 |
| Forward PE | -0.82 |
| Analyst | n/a |
| Ask | 0.38 |
| Volume | 4,653,956 |
| Avg. Volume (20D) | 5,310,906 |
| Open | 0.31 |
| Previous Close | 0.42 |
| Day's Range | 0.29 - 0.39 |
| 52-Week Range | 0.18 - 1.87 |
| Beta | 0.44 |
About PTIX
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York....
Industry Biotechnology
Sector Healthcare
IPO Date Apr 27, 2021
Employees 1
Stock Exchange NASDAQ
Ticker Symbol PTIX
Website https://www.protagenic.com
5 months ago
+13.73%
Protagenic Therapeutics shares are trading higher....
Unlock content with
Pro Subscription
